Transplant Immunology

Aims & Scope

Transplant Immunology will publish up-to-date information on all aspects of the broad field it encompasses.

The journal will be directed at (basic) scientists, tissue typers, transplant physicians and surgeons, and research and data on all immunological aspects of organ-, tissue- and (haematopoietic) stem cell transplantation are of potential interest to the readers of Transplant Immunology.

Original papers, Review articles and Hypotheses will be considered for publication and submitted manuscripts will be rapidly peer-reviewed and published.

They will be judged on the basis of scientific merit, originality, timeliness and quality.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.4
2024	1.60

SJR (SCImago Journal Rank)

Year	Value
2024	0.458

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	68

Journal Rank

Year	Value
2024	12461

Journal Citation Indicator

Year	Value
2024	742

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Xenogeneic extracellular matrix as a scaffold for tissue reconstruction

  Citation: 617

  Authors: Stephen F.

• Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man

  Citation: 328

  Authors: D.K.C., A.H., E., R., A.J., R.M., F.A., Y., E., N.

• High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells

  Citation: 247

  Authors: John S., Paola C., George, Flavia, Anna, Raffaello, Donna, Nicole

• Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: a technical report

  Citation: 221

  Authors: Chris, Vera, Paul J, Ian V

• ARMS-PCR methodologies to determine IL-10, TNF-α, TNF-β and TGF-β1 gene polymorphisms

  Citation: 192

  Authors: Chris, Stephen J, Vera, W Martin, Ian V

• Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

  Citation: 177

  Authors: Keith, Anne, Alexandra, Ludmilla, David, Gaetano, Violet, George, Andreas, Joshua

• Advances in tissue engineering of blood vessels and other tissues

  Citation: 168

  Authors: Laura, Robert

• Pathways of allorecognition: implications for transplantation tolerance

  Citation: 165

  Authors: David S, Robert I

• Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation

  Citation: 162

  Authors: Takaaki, Ying, Mami, Yanling, Shimon, Nagahiro, Kathryn J., Hironori, Mikiko, Shinji

• Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate

  Citation: 157

  Authors: F.C., E., P., P., S.A., H., E.K., P., H.J., M.H.

---